SS Innovations International Inc. (NASDAQ: SSII) announced that it will showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The presentation will include a live robotic telesurgery broadcast from India, where a partial nephrectomy will be performed remotely, demonstrating the platform's remote capabilities. The SSi Mantra will be featured in multiple technical sessions throughout the conference.
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, will participate in several conference presentations covering telesurgery, adoption of robotic surgery, and regulatory developments. The company's presence at SRS 2026 underscores its growing focus on expanding access to minimally invasive surgery through advanced robotics and remote connectivity.
As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric, and telesurgical procedures. Approximately 2,100 physicians have been trained on the platform, which has been utilized across over 170 different surgical procedures. The system has been deployed in multiple countries, reflecting the company's strategy to broaden its global clinical footprint.
The live telesurgery demonstration is expected to highlight the potential of remote surgical capabilities to address healthcare disparities, particularly in underserved regions. SS Innovations positions the SSi Mantra as a cost-effective alternative to established robotic systems, aiming to increase adoption in emerging markets.
For more information about the SRS 2026 Annual Meeting, visit https://ibn.fm/FkgsY. To stay updated on SS Innovations, refer to the company's newsroom at https://ibn.fm/SSII.
The announcement comes as the company continues to expand its clinical evidence and regulatory approvals. The SSi Mantra has received approvals in several countries, and the company is pursuing further clearances to enter additional markets. With over 12,000 procedures completed, the platform's growing experience base supports its value proposition in improving surgical outcomes and accessibility.
